Tempest Therapeutics, Inc. (TPST)

Latest Insider Confidence Score

2026Q1

50.0
Bearish

Company insider confidence (by quarter)

2012Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Angel Matthew — 8,268,495 Feb 6, 2026
Versant Venture Capital VI, L.P. 10% Owner 3,297,115 Aug 12, 2024
Versant Ventures VI GP, L.P. 10% Owner 3,297,115 Aug 12, 2024
Versant Ventures VI GP-GP, LLC 10% Owner 3,297,115 Aug 12, 2024
Versant Vantage II, L.P. 10% Owner 3,297,115 Aug 12, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 4, 2026 Feb 6, 2026 Angel Matthew CEO Neutral 52.5 - 0.00% ✗ -
Feb 6, 2026 Angel Matthew CEO Neutral 52.5 - 0.00% ✗ -
Jan 27, 2026 Jan 28, 2026 Simantov Ronit Director Neutral 52.5 - 0.00% ✗ -
Jan 27, 2026 Jan 28, 2026 NICHOL GEOFFREY Director Neutral 52.5 - 0.00% ✗ -
Jan 27, 2026 Jan 28, 2026 RAAB MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Jan 27, 2026 Jan 28, 2026 Pellizzari Christine A Director Neutral 52.5 - 0.00% ✗ -
Jan 2, 2025 Jan 6, 2025 Brady Stephen R CEO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2025 Jan 6, 2025 Whiting Samuel Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2025 Jan 6, 2025 Trojanowski Justin Corporate Controller Neutral 52.5 - 0.00% ✗ -
Jan 2, 2025 Jan 6, 2025 Maestas Nicholas CFO Neutral 52.5 - 0.00% ✗ -
Aug 8, 2024 Aug 12, 2024 Versant Venture Capital VI, L.P. 10% Owner Sell 20.0 -787,999 -18.35% ✗ $967K
Jul 3, 2024 Jul 8, 2024 Brady Stephen R CEO Buy 95.0 +35,000 307.67% ✗ $73.9K
Jul 2, 2024 Jul 3, 2024 Whiting Samuel Chief Medical Officer Buy 90.0 +4,672 95.33% ✗ $10K
Jun 28, 2024 Jul 2, 2024 Trojanowski Justin Corporate Controller Buy 91.3 +7,500 51.13% ✗ $16.2K
Jun 13, 2024 Jun 14, 2024 Pellizzari Christine A Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 14, 2024 NICHOL GEOFFREY Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 14, 2024 Simantov Ronit Director Neutral 52.5 - 0.00% ✗ -
Jun 13, 2024 Jun 14, 2024 RAAB MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Jan 3, 2024 Jan 5, 2024 Brady Stephen R CEO Neutral 52.5 - 0.00% ✗ -
Jan 3, 2024 Jan 5, 2024 Whiting Samuel Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2024 Jan 5, 2024 Trojanowski Justin Principal Accounting Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2024 Jan 5, 2024 Maestas Nicholas VP of Strategy and Finance Neutral 52.5 - 0.00% ✗ -
Oct 11, 2023 Oct 13, 2023 Brady Stephen R CEO Neutral 52.5 - 0.00% ✗ -
Oct 11, 2023 Oct 13, 2023 Trojanowski Justin Corporate Controller Neutral 52.5 - 0.00% ✗ -
Oct 11, 2023 Oct 13, 2023 Whiting Samuel Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Oct 11, 2023 Oct 13, 2023 Maestas Nicholas VP of Strategy and Finance Neutral 52.5 - 0.00% ✗ -
Jun 15, 2023 Jun 20, 2023 RAAB MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2023 Jun 20, 2023 NICHOL GEOFFREY Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2023 Jun 20, 2023 Pellizzari Christine A Director Neutral 52.5 - 0.00% ✗ -
Jun 15, 2023 Jun 20, 2023 Simantov Ronit Director Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 5, 2023 Whiting Samuel Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 5, 2023 Dubensky Thomas W. President Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 5, 2023 Brady Stephen R CEO Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 5, 2023 Maestas Nicholas VP of Strategy and Finance Neutral 52.5 - 0.00% ✗ -
Jan 3, 2023 Jan 5, 2023 Trojanowski Justin Corporate Controller Neutral 52.5 - 0.00% ✗ -
Oct 3, 2022 Oct 4, 2022 Trojanowski Justin Corporate Controller Neutral 52.5 - 0.00% ✗ -
Oct 4, 2022 Trojanowski Justin Corporate Controller Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Lorenzo Pierre Corporate Controller Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Maestas Nicholas VP of Strategy and Finance Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Whiting Samuel Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Dubensky Thomas W. President Neutral 52.5 - 0.00% ✗ -
Jun 21, 2022 Jun 22, 2022 Brady Stephen R CEO Neutral 52.5 - 0.00% ✗ -
Jun 17, 2022 Jun 22, 2022 Pellizzari Christine A Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2022 Jun 22, 2022 NICHOL GEOFFREY Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2022 Jun 22, 2022 Woiwode Thomas Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2022 Jun 22, 2022 Simantov Ronit Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2022 Jun 22, 2022 RAAB MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2022 May 3, 2022 Woiwode Thomas Director Buy 100.0 +2,118,644 100.00% ✗ $5M
May 3, 2022 Versant Venture Capital VI, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
May 3, 2022 Versant Vantage II, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Jan 7, 2022 Jan 11, 2022 Dubensky Thomas W. President Buy 77.5 +2,000 1.80% ✗ $9.6K
Jan 6, 2022 Jan 10, 2022 Whiting Samuel Chief Medical Officer Buy 90.0 +1,700 845.77% ✗ $8.2K
Jan 10, 2022 Rock Springs Capital Management LP 10% Owner Neutral 52.5 - 0.00% ✗ -
Jan 4, 2022 Jan 6, 2022 Lorenzo Pierre Corporate Controller Neutral 52.5 - 0.00% ✗ -
Jan 4, 2022 Jan 6, 2022 Maestas Nicholas VP of Strategy and Finance Neutral 52.5 - 0.00% ✗ -
Jan 4, 2022 Jan 6, 2022 Whiting Samuel Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 4, 2022 Jan 6, 2022 Brady Stephen R CEO Neutral 52.5 - 0.00% ✗ -
Jan 4, 2022 Jan 6, 2022 Dubensky Thomas W. President Neutral 52.5 - 0.00% ✗ -
Sep 21, 2021 Sep 23, 2021 RAAB MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2021 Sep 20, 2021 NICHOL GEOFFREY Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2021 Sep 20, 2021 Pellizzari Christine A Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2021 Sep 20, 2021 Woiwode Thomas Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2021 Sep 20, 2021 Xu Stella Director Neutral 52.5 - 0.00% ✗ -
Aug 6, 2021 Aug 10, 2021 Simantov Ronit Director Neutral 52.5 - 0.00% ✗ -
Aug 10, 2021 Simantov Ronit Director Neutral 52.5 - 0.00% ✗ -
Jul 12, 2021 Jul 14, 2021 Maestas Nicholas VP of Strategy and Finance Neutral 52.5 - 0.00% ✗ -
Jul 14, 2021 Maestas Nicholas VP of Strategy and Finance Neutral 52.5 - 0.00% ✗ -
Jul 6, 2021 Versant Venture Capital VI, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Jul 1, 2021 Jul 6, 2021 Xu Stella Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2021 Jul 6, 2021 Woiwode Thomas Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2021 Jul 6, 2021 NICHOL GEOFFREY Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2021 Jul 6, 2021 Pellizzari Christine A Director Neutral 52.5 - 0.00% ✗ -
Jul 6, 2021 Pellizzari Christine A Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2021 Jun 30, 2021 Whiting Samuel Chief Medical Officer Neutral 90.0 +201 100.00% ✗ -
Jun 30, 2021 Whiting Samuel Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 25, 2021 Jun 29, 2021 Xu Stella Director Neutral 90.0 +579,710 100.00% ✗ -
Jun 25, 2021 Jun 29, 2021 Dubensky Thomas W. President Neutral 90.0 +111,343 100.00% ✗ -
Jun 25, 2021 Jun 29, 2021 RAAB MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Jun 25, 2021 Jun 29, 2021 Brady Stephen R CEO Neutral 52.5 - 0.00% ✗ -
Jun 25, 2021 Jun 29, 2021 Woiwode Thomas Director Neutral 90.0 +2,176,411 100.00% ✗ -
Jun 25, 2021 Jun 29, 2021 Lorenzo Pierre Corporate Controller Neutral 90.0 +53 100.00% ✗ -
Jun 29, 2021 Xu Stella Director Neutral 52.5 - 0.00% ✗ -
Jun 29, 2021 Brady Stephen R CEO Neutral 52.5 - 0.00% ✗ -
Jun 29, 2021 RAAB MICHAEL Director Neutral 52.5 - 0.00% ✗ -
Jun 29, 2021 Woiwode Thomas Director Neutral 52.5 - 0.00% ✗ -
Jun 29, 2021 Lorenzo Pierre Corporate Controller Neutral 52.5 - 0.00% ✗ -
Jun 29, 2021 Dubensky Thomas W. President Neutral 52.5 - 0.00% ✗ -
Mar 17, 2021 Mar 19, 2021 Owens Julia C. Chair Neutral 52.5 - 0.00% ✗ -
Feb 26, 2021 Mar 2, 2021 Minai-Azary Jennifer Lynn CFO Neutral 52.5 - 0.00% ✗ -
Feb 26, 2021 Mar 2, 2021 Arcudi III Louis J CEO Neutral 52.5 - 0.00% ✗ -
Feb 9, 2021 Minai-Azary Jennifer Lynn CFO Neutral 52.5 - 0.00% ✗ -
Jun 22, 2020 Jun 23, 2020 Nuechterlein Carole Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2020 Jun 23, 2020 HOWE JOHN P MD Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2020 Jun 23, 2020 Gallagher Carol Giltner Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2020 Jun 23, 2020 Hedley Mary Lynne Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2020 Jun 23, 2020 Dable Habib J Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2020 Jun 23, 2020 NICHOL GEOFFREY Director Neutral 52.5 - 0.00% ✗ -
Jun 22, 2020 Jun 23, 2020 Hindman James M. Director Neutral 52.5 - 0.00% ✗ -
May 25, 2020 May 27, 2020 Arcudi III Louis J CFO Neutral 52.5 - 0.00% ✗ -
May 25, 2020 May 27, 2020 Zeidan Ryan Chief Development Officer Neutral 52.5 - 0.00% ✗ -